Docosahexaenoic acid and n-6 docosapentaenoic acid supplementation alter rat skeletal muscle fatty acid composition by Stark, Ken D et al.
BioMed  Central
Page 1 of 11
(page number not for citation purposes)
Lipids in Health and Disease
Open Access Research
Docosahexaenoic acid and n-6 docosapentaenoic acid 
supplementation alter rat skeletal muscle fatty acid composition
Ken D Stark*1, Sun-Young Lim2 and Norman Salem Jr3
Address: 1Laboratory of Nutritional and Nutraceutical Research, Department of Kinesiology, University of Waterloo, Waterloo, ON N2L 3G1, 
Canada, 2Division of Marine Environment & Bioscience, Korea Maritime University, Busan 606-791, Korea and 3Laboratory of Membrane 
Biochemistry and Biophysics, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, 
National Institutes of Health, Bethesda, MD 20892, USA
Email: Ken D Stark* - kstark@uwaterloo.ca; Sun-Young Lim - sylim@hhu.ac.kr; Norman Salem - nsalem@niaaa.nih.gov
* Corresponding author    
Abstract
Background: Docosahexaenoic acid (22:6n-3, DHA) and n-6 docosapentaenoic acid (22:5n-6,
DPAn-6) are highly unsaturated fatty acids (HUFA, ≥ 20 carbons, ≥ 3 double bonds) that differ by
a single carbon-carbon double bond at the Δ19 position. Membrane 22:6n-3 may support skeletal
muscle function through optimal ion pump activity of sarcoplasmic reticulum and electron
transport in the mitochondria. Typically n-3 fatty acid deficient feeding trials utilize linoleic acid
(18:2n-6, LA) as a comparison group, possibly introducing a lower level of HUFA in addition to n-
3 fatty acid deficiency. The use of 22:5n-6 as a dietary control is ideal for determining specific
requirements for 22:6n-3 in various physiological processes. The incorporation of dietary 22:5n-6
into rat skeletal muscles has not been demonstrated previously. A one generation, artificial rearing
model was utilized to supply 22:6n-3 and/or 22:5n-6 to rats from d2 after birth to adulthood. An
n-3 fatty acid deficient, artificial milk with 18:2n-6 was supplemented with 22:6n-3 and/or 22:5n-6
resulting in four artificially reared (AR) dietary groups; AR-LA, AR-DHA, AR-DPAn-6, AR-
DHA+DPAn-6. A dam reared group (DAM) was included as an additional control. Animals were
sacrificed at 15 wks and soleus, white gastrocnemius and red gastrocnemius muscles were
collected for fatty acid analyses.
Results: In all muscles of the DAM group, the concentration of 22:5n-6 was significantly lower than
22:6n-3 concentrations. While 22:5n-6 was elevated in the AR-LA group and the AR-DPAn-6
group, 20:4n-6 tended to be higher in the AR-LA muscles and not in the AR-DPAn-6 muscles. The
AR-DHA+DPAn-6 had a slight, but non-significant increase in 22:5n-6 content. In the red
gastrocnemius of the AR-DPAn-6 group, 22:5n-6 levels (8.1 ± 2.8 wt. %) did not reciprocally
replace the 22:6n-3 levels observed in AR-DHA reared rats (12.2 ± 2.3 wt. %) suggesting a specific
preference/requirement for 22:6n-3 in red gastrocnemius.
Conclusion: Dietary 22:5n-6 is incorporated into skeletal muscles and appears to largely compete
with 22:6n-3 for incorporation into lipids. In contrast, 18:2n-6 feeding tends to result in elevations
of 20:4n-6 and restrained increases of 22:5n-6. As such, 22:5n-6 dietary comparison groups may be
useful in elucidating specific requirements for 22:6n-3 to support optimal health and disease
prevention.
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Background
Docosahexaenoic acid (22:6n-3, DHA) demonstrates
health benefits through various physiological systems
including neurological [1], cardiovascular [2] and inflam-
matory systems [3]. These mechanisms are largely derived
through 22:6n-3 incorporation in place of other fatty
acids into biological membranes and cell signalling mech-
anisms. The fatty acid composition of muscle has been
implicated in obesity and insulin resistance and dietary
intake can modify these compositions [4,5]. Feeding rats
an essential fatty acid deficient diet results in higher peak
twitch tension, reduced twitch contraction and half-relax-
ation times and quicker fatigability as compared with n-6
and n-3 fatty acid enriched diets in soleus and/or extensor
digitorum longus muscles [6].
The impact of dietary fatty acid manipulation on the fatty
acid composition of rat skeletal muscle has been studied
[7-10]. However, only one of these studies, examining a
mixed muscle homogenate, [7] employed a traditional
two generational dietary n-3 fatty acid deficiency model in
which the dam and her offspring are raised on n-3 fatty
acid deficient diets. This study demonstrated that n-6
docosapentaenoic acid (22:5n-6, DPAn-6) increased with
deficiency, but the 22:5n-6 did not reciprocally replace
lost docosahexaenoic acid (22:6n-3, DHA). The remain-
ing studies introduced dietary fatty acid manipulation
protocols post-weaning. The impact of fatty acid manipu-
lation during early development is relevant given recent
evidence demonstrating long-term physiological changes
in the skeletal muscle of offspring with maternal nutrient
restriction [11].
While it is possible to manipulate skeletal muscle 22:6n-3
levels with post-weaning dietary deficiency, it is known
that other tissues, specifically those of the central nervous
system are resistant to loss of 22:6n-3 with post-weaning
deficiency [1]. In addition to two generational models,
artificial rearing models have been recently employed for
n-3 fatty acid and 22:6n-3 deficiency studies in the central
nervous system [12-15]. In n-3 fatty acid deficiency stud-
ies, 22:6n-3 loss is often compensated to some degree by
22:5n-6 [7,16]. These highly unsaturated fatty acids (≥ 20
carbons, ≥ 3 double-bonds, HUFA) differ by only a single
carbon-carbon double bond and are largely incorporated
into the sn-2 position of phospholipids. Studies examin-
ing n-3 fatty acid deficiency often utilize a linoleic acid
(18:2n-6, LA) based diet in comparison to a 22:6n-3 sup-
plemented diet. Dietary 18:2n-6 may be beta-oxidized or
incorporated into phospholipids, [17], but the utilization
of 18:2n-6 for 22:5n-6 synthesis is very low [18] and
22:5n-6 does not completely replace 22:6n-3 concentra-
tions in tissues such as the developing brain [16]. As such,
18:2n-6 feeding relies on elongation and desaturation
activities to generate 22:5n-6 which typically results in
increased in 20:4n-6 in addition to increased 22:5n-6.
Feeding 22:5n-6 to achieve reciprocal replacement of
22:6n-3 in muscle may be a novel and ideal control in
functional muscle studies. Comparative anatomical stud-
ies have demonstrated a link between high frequency con-
traction and high levels of 22:6n-3 in muscles [19]. Both
the sarcoplasmic reticulum and mitochondria of mixed
muscle samples have been demonstrated to have high per-
centages of 22:6n-3 [20]. The fatty acid composition of
skeletal muscle varies by muscle fibre type [21-24], how-
ever the content of 22:5n-6 is typically not reported. Die-
tary substitution of 22:6n-3 with 22:5n-6 has confirmed
an important and specific role for 22:6n-3 in optimal neu-
ral function [12], but there is no data on dietary incorpo-
ration of 22:5n-6 into skeletal muscle. To our knowledge,
there is only one other report of dietary 22:5n-6 feeding,
however, the dietary oil used was also high in 22:6n-3
(10.2% 22:5n-6 and 35.7% 22:6n-3) [25].
The purpose of the present study is to determine if dietary
22:5n-6 is incorporated into rat skeletal muscle lipids after
feeding with a 22:5n-6 oil free of 22:6n-3. The present
study uses a unique artificially reared suckling rat model
that allowed strict control of the type of fatty acids fed and
included: a diet based on 18:2n-6 (AR-LA); and 18:2n-6
diets with either 1% 22:6n-3 (AR-DHA); 1% 22:5n-6 (AR-
DPAn-6); or 1% 22:6n-3 plus 0.4% 22:5n-6 (AR-
DHA+DPAn-6). A dam reared control group (DAM) was
also included. The fatty acid compositions of total lipid
extractions were determined for soleus (slow-twitch oxi-
dative), red gastrocnemius (fast-twitch oxidative) and
white gastrocnemius (fast-twitch glycolytic) muscles such
that a measure of the total lipids in the muscles was
obtained. Given the novel artificial rearing approach in
the present study and the limited data on dietary 22:5n-6
supplementation, complete fatty acid compositions as
detected, are reported rather than selected fatty acids.
Results
Body weight
The body weight of the rats in the present study have been
presented previously [12]. Briefly, the AR groups showed
lower weight gain than the DAM group until the time of
weaning. There were no differences in body weight
between AR and DAM groups by 8 weeks of age and at the
time of sacrifice (15 weeks of age).
Comparison of muscle types
Fatty acid compositions of total lipid extracts from soleus,
red gastrocnemius and white gastrocnemius differed in
relative weight percentages and concentrations in the
dam-reared rats (Table 1). Total fatty acid concentrations
were significantly higher in soleus as compared with redLipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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and white gastrocnemius which were similar. These differ-
ences were mainly a result of much higher concentrations
of monounsaturates (over 3-fold higher than concentra-
tions in red gastrocnemius and approximately 2-fold the
white gastrocnemius concentration), but saturate and pol-
yunsaturate (PUFA) concentrations in soleus were also
significantly higher. Interestingly, concentrations of
HUFA in soleus did not differ from white gastrocnemius
and were significantly less than concentrations in red gas-
trocnemius. When fatty acids were expressed as relative
weight percentages, the fatty acid composition of soleus
tended to resemble white gastrocnemius, except for a sig-
nificantly lower percentage of n-3 HUFA in total HUFA
and total saturates. As compared to red gastrocnemius,
soleus had similar total saturates, much higher total
monounsaturates and lower levels of total PUFA and sub-
classes of PUFA including total HUFA.
The fatty acid composition also varied at the level of indi-
vidual fatty acids (Table 2). Although red gastrocnemius
and soleus had similar weight percentage of total saturates
(41.5 ± 1.15 and 41.5 ± 0.8 wt. %, respectively), red gas-
trocnemius had significantly lower 12:0 and 14:0 and sig-
nificantly higher amounts of 16:0 and 18:0 as compared
with soleus. White gastrocnemius resembled soleus in
regards to 12:0, 14:0 and 18:0, but also had high levels of
16:0 (24.5 ± 1.0 wt. %). Other notable differences
included significantly lower 16:1n-7 and 18:1n-9 in red
gastrocnemius as compared with the others. Red gastroc-
nemius also had the highest percentage of 18:2n-6 (15.0
± 1.3 wt. %) although not significantly different than
soleus (13.6 ± 1.3 wt. %), and the highest percentage of
20:4n-6 (8.9 ± 0.44 wt. %) although not significantly dif-
ferent than white gastrocnemius (6.5 ± 2.2 wt. %). In
regards to n-3 PUFA, red gastrocnemius had the lowest
18:3n-3, but the highest percentages of 22:5n-3 and DHA
(11.7 ± 1.1 wt. %). DHA was the lowest in soleus (3.9 ±
1.6 wt. %) and intermediate in white gastrocnemius (7.7
± 2.0 wt. %).
Effect of dietary manipulations
There were no significant differences in the total concen-
tration of all fatty acids with dietary treatment of each
muscle; therefore comparisons of dietary treatments are
restricted to relative weight percentages of total fatty acids.
The percentage of 22:5n-6 was significantly higher in the
AR-LA and AR-DPAn-6 groups in all muscles as compared
to rats with dietary 22:6n-3, including the AR-
DHA+DPAn-6 group. In fact, the percentage of 22:5n-6 in
the AR-DHA+DPAn-6 group was not statistically different
than either the DAM or the AR-DHA groups for all mus-
cles. The potential ability of 22:5n-6 to replace 22:6n-3 in
skeletal muscle was investigated by comparing the per-
centage of 22:5n-6 in the AR-DPAn-6 and AR-LA groups to
the percentage of 22:6n-3 in the AR-DHA in each muscle.
In soleus and white gastrocnemius, there were no differ-
ences, however in the red gastrocnemius, the amount of
22:5n-6 in the AR-DPAn-6 (8.1 ± 2.8 wt. %) and AR-LA
(5.9 ± 1.9 wt. %) groups were significantly lower than the
amount of 22:6n-3 in the AR-DHA group (12.2 ± 2.3 wt.
%). While total HUFA was not significantly different in
any of the muscles, the sum of 22:6n-3 + 22:5n-6 was sig-
nificantly lower in the red gastrocnemius of the AR-DPAn-
6 (9.2 ± 3.0 wt. %) and AR-LA (6.8 ± 2.1 wt. %) groups as
compared to the AR-DHA group (13.5 ± 2.6 wt. %).
In the white gastrocnemius, the percentage of 20:4n-6 was
significantly higher in the AR-LA group as compared with
the AR-DHA+DPAn-6 group, with a tendency for a differ-
ence from the other groups as P < 0.10 for all individual
comparisons (P = 0.098 versus DAM, P = 0.08 versus AR-
DPAn-6, and P = 0.07 versus AR-DHA). Interestingly, the
percentage of 20:4n-6 was the highest numerically, but
not statistically different in the AR-LA groups of the red
gastrocnemius and soleus. The percentage of 18:2n-6 was
significantly higher in all muscles in the DAM group as
compared to the AR rats. In white gastrocnemius, the AR-
DPAn-6, AR-DHA+DPAn-6 and AR-DHA groups also had
percentages of 18:2n-6 that were significantly lower than
the AR-LA group. The total n-6 PUFA percentage in muscle
tended to be lower in the AR-DHA+DPAn-6 and AR-DHA
groups and higher in the AR-LA and AR-DPAn-6 groups,
mainly as a result of the higher percentage of 22:5n-6.
There was an exception in soleus as the highest observed
percentage of total n-6 PUFA was in the DAM group
because of a significantly higher percentage of 18:2n-6.
Total PUFA did not differ in red gastrocnemius and white
gastrocnemius, but was significantly lower in soleus in the
artificially reared as compared to the dam-reared rats
(Tables 3, 4, 5). Total HUFA did not change with dietary
fatty acid supplementation for any of the muscles. In all
muscles, 22:6n-3 percentages were significantly lower in
the 22:6n-3 free diets (AR-LA and AR-DPAn-6 groups) and
the AR-DHA group had 22:6n-3 levels similar to the DAM
group. In the AR-DHA+DPAn-6 group, 22:6n-3 tended to
be lower in the muscles, but the only significant difference
was in white gastrocnemius (5.4 ± 1.3 wt. % versus 7.7 ±
1.8 wt. % in dam reared). The DAM group had signifi-
cantly higher 18:3n-3 and 22:5n-3 in all muscles, and sig-
nificantly higher 20:5n-3 in red gastrocnemius and soleus
as compared with the AR rats.
Total n-3 PUFA percentages were significantly lower in the
AR-LA and AR-DPAn-6 groups and similar for the DAM
group and the AR-DHA group in all muscles. In white gas-
trocnemius and soleus, the total n-3 PUFA percentage in
the AR-DHA+DPAn-6 group was significantly lower than
the DAM group, but not the AR-DHA group. The AR-LA
and AR-DPAn-6 groups had significantly lower percent-Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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ages of n-3 HUFA in total HUFA than the other groups in
all muscles. The response of this parameter to the inclu-
sion of 22:6n-3 in the diet was not homogeneous for all
three muscles. In soleus, there were no differences
between the DAM, AR-DHA+DPAn-6 and AR-DHA
groups. In red gastrocnemius, the DAM group (55.8 ±
1.8%) and AR-DHA group (52.4 ± 3.0%) were similar, but
the AR-DHA+DPAn-6 group (47.7 ± 3.3%) had a signifi-
cantly lower percentage of n-3 HUFA in total HUFA. In
white gastrocnemius, the DAM, AR-DHA and AR-
DHA+DPAn-6 groups were statistically different for each
muscle at 54.2 ± 2.0%, 48.6 ± 3.6% and 43.8 ± 4.1%,
respectively.
There were also differences observed in the saturated and
monounsaturated fatty acids. Total saturates were signifi-
cantly lower in all muscles of the AR rats as compared to
the DAM group. This was largely driven by higher percent-
ages in 12:0, 14:0, 20:0, 24:0 with a tendency for higher
percentages of 18:0 and 22:0 in the DAM group muscles,
while the percentage of 16:0 was largely similar. Total per-
centage of monounsaturates was lower in the DAM group,
although the difference was not statistically different in
the red gastrocnemius. This was mainly a result of signifi-
cantly higher 18:1n-9 in all muscles.
Discussion
The present study identifies a novel research method that
can assist in determining the requirement of 22:6n-3 for
proper skeletal muscle function including insulin resist-
ance and diabetes. This study also confirms that dietary
fatty acid intake can influence the fatty acid composition
of muscle [7,9,10,26-28] and that the fatty acid composi-
tion of rat skeletal muscle differs significantly dependent
on muscle fibre type [21-24]. The present study is the first
to investigate the effect of 22:5n-6 supplementation via
artificial rearing on the fatty acid composition of skeletal
muscle and suggests that there may be subtle differences
in how specific muscle fibres respond to dietary chal-
lenges.
In the present study, the percentage of total HUFA was not
affected by the dietary manipulations although the
amount of HUFA appears to be specific to each muscle
type. There were obvious differences in the percentage of
n-3 HUFA in total HUFA, as the diets without 22:6n-3 had
markedly lower n-3 HUFA. The AR-LA group, which had
no preformed dietary HUFA, did not differ however in
total HUFA, and had the lowest percentage of n-3 HUFA
and the highest 20:4n-6 wt. % in each muscle (although
not statistically different than the AR-DPAn-6 group). Cal-
culations for 80% power indicate that to determine signif-
icant differences (alpha = 0.05, two-tailed) between the
percentage of 20:4n-6 in the AR-LA group and the AR-
DPAn-6 group, n = 17, n = 31 and n = 53 would be
required for each group for white gastrocnemius, red gas-
trocnemius and soleus, respectively. Although highly
speculative, it appears that the AR-LA group may have had
higher rates of elongation and desaturation of 18:2n-6 to
20:4n-6. Fatty acid isotope studies are required to verify
this hypothesis.
The observation that 22:6n-3 levels are low in muscles
when it is absent in the diet was expected. The 22:6n-3 lev-
Table 1: Relative Percentage and Concentrations of Sums and Classes of Fatty Acids in Soleus and Red and White Gastrocnemius 
Muscles from Dam-Reared Rats*
Soleus Red Gastrocnemius White Gastrocnemius
(weight % of total fatty acids)
Total saturates 41.5 ± 0.8a 41.5 ± 1.2a 43.5 ± 1.3b
Total monounsaturates 28.7 ± 4.6a 17.4 ± 1.1b 24.4 ± 4.1a
Total PUFA 26.0 ± 4.8a 38.7 ± 1.6b 28.7 ± 4.8a
Total n-6 PUFA 20.7 ± 3.2a 25.4 ± 1.5b 19.4 ± 2.8a
Total n-3 PUFA 5.4 ± 1.6a 13.3 ± 1.1b 9.3 ± 2.1c
Total HUFA 11.5 ± 3.9a 23.3 ± 1.4b 16.2 ± 4.7a
% of n-3 HUFA in HUFA 39.1 ± 2.6a 55.8 ± 1.7b 54.1 ± 2.2b
(concentration, μg/g)
Total saturates 10828 ± 3784a 5520 ± 607b 6934 ± 1772b
Total monounsaturates 7813 ± 3881a 2317 ± 307b 3988 ± 1505b
Total PUFA 6441 ± 1159a 5130 ± 326b 4408 ± 473b
Total n-6 PUFA 5155 ± 1085a 3359 ± 206b 2995 ± 405b
Total n-3 PUFA 1285 ± 83a 1770 ± 209b 1413 ± 105a
Total HUFA 2711 ± 70a 3088 ± 294b 2425 ± 152a
Total fatty acids 26102 ± 9254a 13278 ± 1188b 15868 ± 3831b
*Values are means ± SD; n = 6. Values in a row not sharing a roman superscript are significantly different at P < 0.05 by Tukey's honestly significantly 
difference test after a significant F-value (P < 0.05) by repeated measures ANOVA. PUFA, polyunsaturated fatty acids; HUFA, highly unsaturated 
fatty acids (≥ 20 carbons, ≥ 3 carbon-carbon double bonds).Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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els presently observed in the AR-LA group (0.32 wt. % in
soleus, 0.89 wt. % in red and 0.58 wt. % in white gastroc-
nemius) are in the same range as the 1.5 wt. % in phos-
phatidylethanolamine, 0.84 wt. % in phosphatidylserine
+ phosphatidylinositol and 0.14 wt. % in phosphatidyl-
choline reported by Tinoco et al. [7] and lower than post-
weaning deficiency studies [8-10]. It appears that feeding
22:5n-6 with 22:6n-3 may have resulted in some compe-
tition for incorporation into muscle lipids, but the only
significant difference was a lower 22:6n-3 wt. % in white
gastrocnemius as compared to the DAM group. It appears
that there is a preference for 22:6n-3 incorporation over
22:5n-6 into skeletal muscle. In the AR-DHA+DPAn-6
group, the diet provided 22:6n-3 and 22:5n-6 in a ratio of
2.5 to 1 while in muscle tissue composition it was 4.0 to
1 in soleus, 4.8 to 1 in white and 5.6 to 1 in red gastrocne-
mius. It was also observed that 22:5n-6 feeding did not
result in a reciprocal replacement of 22:6n-3 in red gas-
trocnemius, possibly due to the high levels of 22:6n-3 in
this tissue or possibly reflecting a highly selective mecha-
nism for 22:6n-3 incorporation in red gastrocnemius. This
ability to discriminate 22:5n-6 and 22:6n-3 has been
shown in brain tissue in the same animals with the ratio
of 22:6n-3 to 22:5n-6 in brain of 12.7 to 1 in the AR-
DHA+DPAn-6 group. In the AR-DPAn-6 group, 22:5n-6
was 7.4 ± 0.3 wt. % and 22:6n-3 was 4.7 ± 0.3 wt. %, while
in the AR-DHA group, 22:5n-6 was only 0.70 ± 0.27 wt. %
and 22:6n-3 was 11.6 ± 0.4 wt. % [12].
Both 22:5n-6 and 22:6n-3 are HUFAs that are found pre-
dominantly in, and potentially compete for the sn-2 posi-
tion of phospholipids. HUFA incorporation into neutral
lipids such as triacylglycerols is often minor and undetec-
table as demonstrated recently in the rat [24]. The fatty
acid content of lipid fractions of soleus, red and white gas-
trocnemius have been reported previously [21] with red
gastrocnemius having the highest concentration of fatty
acids in phospholipids and soleus having the highest con-
centration of fatty acids in triacylglycerols. In the present
study, soleus muscle had the highest fatty acid content,
but also the lowest percentage of total HUFA, although
not significantly different than white gastrocnemius. In
muscle, the sum of 16:0, 18:1n-9 and 18:2n-6 consists of
approximately 75–85% of the total fatty acid content of
Table 2: Composition of Individual Fatty Acids in Soleus and Red and White Gastrocnemius Muscles from Dam-Reared Rats*
Soleus Red Gastrocnemius White Gastrocnemius
(weight % of total fatty acids)
12:0 6.6 ± 2.3a 2.1 ± 0.8b 5.1 ± 1.9a
14:0 5.2 ± 1.1a 2.3 ± 0.4b 4.3 ± 1.2a
16:0 DMA 1.0 ± 0.5a 2.0 ± 0.4b 1.4 ± 0.4ab
16:0 19.4 ± 1.0a 21.7 ± 1.0b 24.5 ± 1.0b
18:0 DMA 0.53 ± 0.29 0.92 ± 0.25 0.75 ± 0.25
18:0 8.6 ± 2.4a 12.2 ± 0.6b 7.3 ± 1.0a
20:0 0.09 ± 0.02a 0.08 ± 0.02a 0.05 ± 0.01b
22:0 0.08 ± 0.02ab 0.09 ± 0.03a 0.05 ± 0.01b
24:0 0.13 ± 0.06ab 0.18 ± 0.02a 0.10 ± 0.02b
16:1 n-7 7.2 ± 1.8a 3.3 ± 0.3b 6.3 ± 1.5a
18:1 DMA 0.06 ± 0.02a 0.22 ± 0.05b 0.19 ± 0.06b
18:1 n-9 17.2 ± 2.7a 10.3 ± 1.0b 14.2 ± 2.7a
18:1 n-7 4.0 ± 0.3a 3.3 ± 0.2b 3.6 ± 0.2b
20:1 n-9 0.09 ± 0.03 0.06 ± 0.02 0.08 ± 0.02
24:1 n-9 0.12 ± 0.04ab 0.14 ± 0.01a 0.08 ± 0.02b
18:2 n-6 13.6 ± 1.3a 15.0 ± 1.3a 11.8 ± 0.8b
18:3 n-6 0.03 ± 0.01 0.03 ± 0.01 0.03 ± 0.01
20:2 n-6 0.06 ± 0.01 0.08 ± 0.05 0.05 ± 0.01
20:3 n-6 0.27 ± 0.07a 0.44 ± 0.05b 0.34 ± 0.09ab
20:4 n-6 6.0 ± 1.9a 8.9 ± 0.4b 6.5 ± 2.2ab
22:4 n-6 0.42 ± 0.09a 0.39 ± 0.03a 0.27 ± 0.09b
22:5 n-6 0.27 ± 0.11a 0.51 ± 0.07b 0.36 ± 0.17ab
18:3 n-3 0.82 ± 0.23a 0.34 ± 0.06b 0.62 ± 0.18a
20:5 n-3 0.07 ± 0.02a 0.13 ± 0.03b 0.10 ± 0.03ab
22:5 n-3 0.58 ± 0.19a 1.18 ± 0.07b 0.87 ± 0.24c
22:6 n-3 3.9 ± 1.6a 11.7 ± 1.1b 7.7 ± 2.0c
*Values are mean ± SD; n = 6. Values in a row not sharing a roman superscript are significantly different at P < 0.05 by Tukey's honestly significantly 
difference test after a significant F-value (P < 0.05) by repeated measures ANOVA. DMA, dimethyl acetal.Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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the triacylglycerol fraction [21,24]. These three fatty acids
can also be incorporated into phospholipids, but 18:1n-9
is predominantly found in neutral lipids. In the present
study, the percentages of 18:1n-9, and 12:0 and 14:0 (also
predominantly found in triacylglycerols) were signifi-
cantly higher in soleus of the dam-reared rats.
The lipid class composition greatly influences the overall
fatty acid composition of a tissue. In addition, the propor-
tion of muscle membranes; the sarcolemma, sarcoplasmic
reticulum and mitochondria, differ between muscle fibre
types [29,30]. Mixed hind limb muscle preparations of
sarcolemma, fragmented sarcoplasmic reticulum and
mitochondria differ in fatty acid composition, which is
not surprising given differences in polar and neutral lipid
concentrations and ratios, neutral lipid composition, and
phospholipid composition in these subcellular mem-
branes [20,31,32]. In the presently analyzed muscle fibre
types; white gastrocnemius fibres are the largest in diame-
ter, have the highest amount of sarcoplasmic reticulum
and the lowest mitochondria content, red gastrocnemius
fibres are moderate in diameter, moderate in the amount
Table 3: Fatty Acid Composition of Rat Soleus After Dietary Supplementation with 22:6n-3 and 22:5n-6*
Artificially reared
Dam reared (n = 7) AR-LA (n = 7) AR-DPAn-6 (n = 7) AR-DHA+DPAn-6 (n = 8) AR-DHA (n = 7)
Fatty acids (weight % of total fatty acids)
12:0 6.3 ± 2.2a 2.55 ± 0.46b 2.53 ± 0.45b 2.55 ± 0.70b 2.63 ± 0.73b
14:0 5.1 ± 1.1a 3.02 ± 0.27b 3.03 ± 0.25b 3.12 ± 0.40b 3.07 ± 0.51b
16:0 DMA 0.93 ± 0.42 0.75 ± 0.25 0.77 ± 0.37 0.66 ± 0.25 0.67 ± 0.36
16:0 20.1 ± 2.0 20.6 ± 1.6 20.8 ± 0.9 21.6 ± 1.0 20.3 ± 0.6
18:0 DMA 0.54 ± 0.27 0.26 ± 0.12 0.30 ± 0.17 0.28 ± 0.15 0.27 ± 0.15
18:0 8.4 ± 2.2 6.7 ± 1.7 6.6 ± 1.7 5.6 ± 1.4 6.4 ± 2.6
20:0 0.10 ± 0.02a 0.05 ± 0.02b 0.05 ± 0.01b 0.05 ± 0.02b 0.06 ± 0.03b
22:0 0.11 ± 0.08 0.04 ± 0.02 0.05 ± 0.02 0.05 ± 0.05 0.05 ± 0.03
24:0 0.15 ± 0.09a 0.06 ± 0.02b 0.07 ± 0.03ab 0.08 ± 0.06ab 0.09 ± 0.05ab
Total saturates 41.6 ± 0.8a 34.0 ± 2.1b 34.2 ± 2.4b 34.0 ± 1.6b 33.5 ± 2.1b
16:1 n-7 7.3 ± 1.6 7.8 ± 1.4 7.6 ± 1.0 8.3 ± 1.8 7.5 ± 2.3
18:1 DMA 0.08 ± 0.06 0.07 ± 0.02 0.08 ± 0.04 0.10 ± 0.11 0.08 ± 0.05
18:1 n-9 17.3 ± 2.5a 31.2 ± 3.7b 31.6 ± 4.2b 32.8 ± 3.8b 32.1 ± 5.5b
18:1 n-7 3.93 ± 0.36 4.55 ± 0.61 4.40 ± 0.50 4.27 ± 0.45 4.38 ± 0.33
20:1 n-9 0.09 ± 0.02a 0.19 ± 0.03b 0.18 ± 0.05b 0.20 ± 0.04b 0.20 ± 0.05b
24:1 n-9 0.13 ± 0.04 0.12 ± 0.04 0.11 ± 0.04 0.12 ± 0.05 0.14 ± 0.07
Total monounsaturates 28.8 ± 4.2a 44.0 ± 5.2b 44.0 ± 5.1b 45.8 ± 5.3b 44.4 ± 7.9b
18:2 n-6 13.1 ± 1.9a 8.4 ± 1.0b 8.24 ± 0.77b 7.82 ± 0.52b 8.4 ± 1.2b
18:3 n-6 0.03 ± 0.01a 0.03 ± 0.01b 0.024 ± 0.004b 0.022 ± 0.004ab 0.022 ± 0.004ab
20:2 n-6 0.06 ± 0.01a 0.04 ± 0.01b 0.04 ± 0.01b 0.04 ± 0.01b 0.05 ± 0.01ab
20:3 n-6 0.27 ± 0.06 0.22 ± 0.06 0.23 ± 0.07 0.20 ± 0.05 0.20 ± 0.07
20:4 n-6 5.8 ± 1.7 6.2 ± 1.8 5.4 ± 1.7 4.2 ± 1.4 4.9 ± 2.4
22:4 n-6 0.40 ± 0.09ab 0.56 ± 0.14a 0.41 ± 0.11ab 0.27 ± 0.03b 0.31 ± 0.14b
22:5 n-6 0.27 ± 0.10a 2.26 ± 0.73b 3.03 ± 0.99b 0.78 ± 0.29a 0.56 ± 0.32a
Total n-6 PUFA 19.9 ± 3.5a 17.7 ± 3.5ab 17.3 ± 3.2ab 13.3 ± 1.9b 14.4 ± 3.7b
18:3 n-3 0.78 ± 0.23a 0.03 ± 0.01b 0.023 ± 0.003b 0.03 ± 0.01b 0.04 ± 0.04b
20:5 n-3 0.08 ± 0.02a -- 0.02 ± 0.01b 0.025 ± 0.003b
22:5 n-3 0.59 ± 0.19a 0.04 ± 0.02b 0.04 ± 0.01b 0.06 ± 0.03b 0.08 ± 0.03b
22:6 n-3 4.3 ± 1.7a 0.32 ± 0.14b 0.44 ± 0.32b 3.2 ± 2.0a 3.7 ± 2.1a
Total n-3 PUFA 5.7 ± 1.7a 0.40 ± 0.16b 0.50 ± 0.32b 3.3 ± 2.0c 3.8 ± 2.1ac
Total PUFA 25.6 ± 4.5a 18.1 ± 3.7b 17.8 ± 3.4b 16.6 ± 3.9b 18.3 ± 5.7b
Total HUFA 11.7 ± 3.6 9.6 ± 2.8 9.5 ± 3.0 8.7 ± 3.6 9.8 ± 5.0
% of n-3 HUFA in HUFA 41.3 ± 6.3a 3.8 ± 0.6b 4.9 ± 2.7b 35.0 ± 6.9a 38.2 ± 3.12a
Total FA (mg/g) 26.1 ± 8.5 34.5 ± 10.6 37.4 ± 15.6 43.2 ± 17.2 40.0 ± 19.5
*Values are mean ± SD. Values in a row not sharing a roman superscript are significantly different at P < 0.05 by Tukey's honestly significantly 
difference test after a significant F-value (P < 0.05) by one-way ANOVA. AR-LA, 18:2n-6 artificial reared diet; AR-DPAn-6, 22:5n-6 artificial reared 
diet; AR-DHA+DPAn-6, 22:6n-3 + 22:5n-6 artificial reared diet; AR-DHA, 22:6n-3 artificial reared diet; DMA, dimethyl acetal; PUFA, 
polyunsaturated fatty acids; HUFA, highly unsaturated fatty acids (≥ 20 carbons, ≥ 3 carbon-carbon double bonds).Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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of sarcoplasmic reticulum and have highest mitochondria
content, and, soleus fibres are the smallest in diameter
(therefore the highest sarcolemma content), have the low-
est amount of sarcoplasmic reticulum and moderate mito-
chondria content.
The sarcolemma is unique in that the neutral lipid content
is approximately equivalent to the phospholipid content
and that neutral lipid composition approaches an even
distribution between triacylglycerols, non-esterified fatty
acids, cholesterol and cholesterol esters. In both the sarco-
plasmic reticulum and mitochondria, phospholipids con-
sist of approximately 80% of total lipids with
triacylglycerol being the dominant neutral lipid and both
fractions have similarly high percentages of 22:6n-3
(approximately 20%) [20]. Mitochondria have a higher
percentage of phosphatidylethanolamine that has higher
22:6n-3 content than phosphatidylcholine [33]. How-
ever, mitochondrion also has higher levels of cardiolipin,
which contains primarily 18:2n-6 and reportedly little to
no DHA [31]. The significantly higher percentage of 18:0
in red gastrocnemius is also indicative of a higher propor-
Table 4: Fatty Acid Composition of Rat Red Gastrocnemius After Dietary Supplementation with 22:6n-3 and 22:5n-6*
Artificially reared
Dam reared (n = 8) AR-LA (n = 7) AR-DPA (n = 7) AR-DHA+DPA (n = 8) AR-DHA (n = 7)
Fatty acids (weight % of total fatty acids)
12:0 2.10 ± 0.84a 0.96 ± 0.53b 1.07 ± 0.76ab 1.00 ± 0.88b 0.84 ± 0.41b
14:0 2.44 ± 0.54a 1.62 ± 0.55ab 1.75 ± 0.69ab 1.60 ± 0.69ab 1.48 ± 0.48b
16:0 DMA 1.86 ± 0.44 1.37 ± 0.41 1.41 ± 0.46 1.71 ± 0.64 1.89 ± 0.62
16:0 22.1 ± 1.1a 22.5 ± 1.1ab 23.8 ± 1.5b 22.7 ± 0.8ab 22.2 ± 1.1ab
18:0 DMA 0.85 ± 0.26a 0.44 ± 0.19b 0.49 ± 0.16ab 0.57 ± 0.29ab 0.69 ± 0.29ab
18:0 11.9 ± 0.8 10.7 ± 2.1 9.9 ± 2.5 10.6 ± 2.3 10.5 ± 1.4
20:0 0.08 ± 0.02a 0.05 ± 0.01b 0.05 ± 0.02b 0.06 ± 0.01b 0.06 ± 0.01ab
22:0 0.08 ± 0.03 0.06 ± 0.01 0.05 ± 0.02 0.06 ± 0.02 0.08 ± 0.03
24:0 0.17 ± 0.02a 0.10 ± 0.02bc 0.09 ± 0.03b 0.13 ± 0.02cd 0.16 ± 0.03ad
Total saturates 41.6 ± 1.0a 37.8 ± 1.7b 38.6 ± 1.0b 38.4 ± 1.6b 37.9 ± 1.6b
16:1 n-7 3.44 ± 0.63 3.7 ± 1.8 4.1 ± 2.0 3.2 ± 1.2 3.19 ± 0.86
18:1 DMA 0.20 ± 0.06a 0.23 ± 0.09ab 0.24 ± 0.12ab 0.33 ± 0.14ab 0.39 ± 0.14b
18:1 n-9 10.6 ± 1.7a 18.6 ± 5.7ab 19.6 ± 7.1b 17.6 ± 7.0ab 17.7 ± 4.9ab
18:1 n-7 3.34 ± 0.19 3.70 ± 0.55 3.59 ± 0.30 3.70 ± 0.39 3.84 ± 0.40
20:1 n-9 0.07 ± 0.02a 0.13 ± 0.03b 0.14 ± 0.04b 0.12 ± 0.05b 0.11 ± 0.03ab
24:1 n-9 0.16 ± 0.04 0.15 ± 0.09 0.13 ± 0.05 0.18 ± 0.07 0.17 ± 0.03
Total monounsaturates 17.9 ± 2.3 26.5 ± 7.7 27.8 ± 9.1 25.2 ± 8.3 25.4 ± 5.6
18:2 n-6 14.5 ± 1.5a 12.1 ± 1.7b 10.3 ± 1.4b 10.2 ± 0.9b 10.3 ± 1.0b
18:3 n-6 0.03 ± 0.01ab 0.04 ± 0.01a 0.03 ± 0.01ab 0.03 ± 0.01b 0.03 ± 0.01ab
20:2 n-6 0.08 ± 0.05a 0.04 ± 0.01b 0.04 ± 0.01b 0.04 ± 0.01b 0.04 ± 0.01ab
20:3 n-6 0.43 ± 0.05 0.46 ± 0.12 0.43 ± 0.11 0.46 ± 0.15 0.42 ± 0.08
20:4 n-6 8.9 ± 1.0 11.8 ± 3.1 9.8 ± 3.8 9.2 ± 2.7 9.1 ± 1.5
22:4 n-6 0.38 ± 0.04a 0.92 ± 0.24b 0.62 ± 0.23c 0.39 ± 0.08a 0.37 ± 0.07a
22:5 n-6 0.53 ± 0.07a 5.9 ± 1.9b 8.1 ± 2.8b 1.97 ± 0.57a 1.30 ± 0.43a
Total n-6 PUFA 24.8 ± 2.2abc 31.3 ± 6.3b 29.3 ± 8.0bc 22.3 ± 3.8ac 21.6 ± 2.5a
18:3 n-3 0.35 ± 0.07a 0.02 ± 0.01b 0.02 ± 0.01b 0.03 ± 0.01b 0.02 ± 0.01b
20:5 n-3 0.13 ± 0.03a -- 0.03 ± 0.01b 0.04 ± 0.02b
22:5 n-3 1.18 ± 0.11a 0.11 ± 0.03b 0.09 ± 0.03b 0.17 ± 0.05b 0.19 ± 0.06b
22:6 n-3 11.6 ± 1.0a 0.89 ± 0.25b 1.14 ± 0.50b 11.0 ± 3.7a 12.2 ± 2.3a
Total n-3 PUFA 13.2 ± 1.1a 1.02 ± 0.27b 1.24 ± 0.51b 11.2 ± 3.7a 12.4 ± 2.4a
Total PUFA 38.1 ± 2.7 32.3 ± 6.5 30.5 ± 8.2 33.5 ± 7.3 34.0 ± 4.7
Total HUFA 23.1 ± 2.0 20.1 ± 5.4 20.2 ± 7.2 23.2 ± 4.2 23.6 ± 4.2
% of n-3 HUFA in HUFA 55.8 ± 1.8a 5.02 ± 0.30b 6.5 ± 2.8b 47.7 ± 3.3c 52.4 ± 3.0a
Total FA (mg/g) 13.5 ± 1.7 16.4 ± 6.5 16.7 ± 6.7 17.2 ± 8.1 14.3 ± 2.9
*Values are mean ± SD. Values in a row not sharing a roman superscript are significantly different at P < 0.05 by Tukey's honestly significantly 
difference test after a significant F-value (P < 0.05) by one-way ANOVA. AR-LA, 18:2n-6 artificial reared diet; AR-DPAn-6, 22:5n-6 artificial reared 
diet; AR-DHA+DPAn-6, 22:6n-3 + 22:5n-6 artificial reared diet; AR-DHA, 22:6n-3 artificial reared diet; DMA, dimethyl acetal; PUFA, 
polyunsaturated fatty acids; HUFA, highly unsaturated fatty acids (≥ 20 carbons, ≥ 3 carbon-carbon double bonds).Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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tion of phosphatidyl-ethanolamine in phospholipids
[34]. The high percentage of 22:6n-3 observed in red gas-
trocnemius in the present study likely serves as structural
cofactors to support fast oxidative activities [19].
Although exercise training has also been demonstrated to
result in changes in fatty acid composition [4,8,35,36]
and phospholipid molecular species [37], it is unlikely a
factor in the differences observed in the present study.
Motor activity was measured by a video image analyzer
(Videomax V, Columbus Instruments, Columbus Ohio,
USA) and presented previously [12]. Briefly, the AR-
DPAn-6 group spent more time moving than the DAM,
AR-DHA and AR-DHA+DPAn-6 groups, but there were no
differences between the groups in total moving distance.
Therefore, a training effect is unlikely and dietary manip-
ulations are probably responsible for the observed differ-
ences in skeletal muscle fatty acids.
Conclusion
Overall, the present study demonstrates that animals fed
22:5n-6 could be an important comparison group when
Table 5: Fatty Acid Composition of Rat White Gastrocnemius After Dietary Supplementation with 22:6n-3 and 22:5n-6*
Artificially reared
Dam reared (n = 7) AR-LA (n = 7) AR-DPA (n = 6) AR-DHA+DPA (n = 8) AR-DHA (n = 7)
Fatty acids (weight % of total fatty acids)
12:0 5.0 ± 1.8a 1.50 ± 0.85b 1.98 ± 0.54b 2.08 ± 0.24b 1.93 ± 0.68b
14:0 4.3 ± 1.1a 2.11 ± 0.69b 2.68 ± 0.48b 2.73 ± 0.21b 2.49 ± 0.45b
16:0 DMA 1.35 ± 0.41 1.22 ± 0.55 0.95 ± 0.39 1.03 ± 0.25 1.17 ± 0.32
16:0 24.7 ± 1.0 26.0 ± 1.9 25.7 ± 0.4 25.9 ± 1.0 25.0 ± 1.2
18:0 DMA 0.71 ± 0.26a 0.41 ± 0.17b 0.35 ± 0.21b 0.36 ± 0.10b 0.43 ± 0.17ab
18:0 7.2 ± 0.9a 6.9 ± 1.7ab 5.7 ± 1.6ab 5.2 ± 0.8b 5.7 ± 1.5ab
20:0 0.05 ± 0.01a 0.04 ± 0.01ab 0.03 ± 0.01b 0.03 ± 0.01b 0.04 ± 0.01ab
22:0 0.05 ± 0.01a 0.04 ± 0.01ab 0.03 ± 0.01b 0.03 ± 0.01b 0.03 ± 0.01ab
24:0 0.10 ± 0.02a 0.06 ± 0.02b 0.05 ± 0.02b 0.06 ± 0.02b 0.08 ± 0.03ab
Total saturates 43.4 ± 1.3a 38.4 ± 2.5b 37.5 ± 1.0b 37.4 ± 0.9b 36.8 ± 1.3b
16:1 n-7 6.3 ± 1.4 5.4 ± 1.6 7.1 ± 2.0 7.0 ± 1.5 6.2 ± 1.9
18:1 DMA 0.18 ± 0.07 0.26 ± 0.08 0.21 ± 0.12 0.27 ± 0.08 0.30 ± 0.10
18:1 n-9 14.7 ± 2.8a 21.8 ± 7.3ab 27.0 ± 4.4b 27.6 ± 2.5b 25.9 ± 5.0b
18:1 n-7 3.60 ± 0.19a 3.78 ± 0.41ab 3.86 ± 0.25ab 4.04 ± 0.34ab 4.20 ± 0.34b
20:1 n-9 0.08 ± 0.02a 0.14 ± 0.05b 0.15 ± 0.05b 0.16 ± 0.02b 0.14 ± 0.03b
24:1 n-9 0.09 ± 0.04 0.10 ± 0.04 0.08 ± 0.03 0.10 ± 0.04 0.12 ± 0.05
Total monounsaturates 24.9 ± 4.0a 31.5 ± 8.8ab 38.4 ± 6.3b 39.1 ± 3.6b 36.9 ± 6.1b
18:2 n-6 11.6 ± 1.0a 10.0 ± 0.9b 8.1 ± 1.2c 7.7 ± 0.7c 8.3 ± 1.0c
18:3 n-6 0.033 ± 0.005ab 0.037 ± 0.003a 0.029 ± 0.004bc 0.025 ± 0.003c 0.027 ± 0.003c
20:2 n-6 0.05 ± 0.01a 0.04 ± 0.01b 0.03 ± 0.01b 0.03 ± 0.01b 0.03 ± 0.01b
20:3 n-6 0.34 ± 0.08 0.44 ± 0.16 0.32 ± 0.09 0.29 ± 0.07 0.31 ± 0.08
20:4 n-6 6.4 ± 2.0ab 9.8 ± 3.9a 6.2 ± 2.2ab 5.4 ± 1.3b 6.2 ± 2.2ab
22:4 n-6 0.27 ± 0.08a 0.81 ± 0.28b 0.42 ± 0.12a 0.24 ± 0.05a 0.25 ± 0.07a
22:5 n-6 0.37 ± 0.16a 4.5 ± 1.6b 5.0 ± 1.8b 1.17 ± 0.29a 0.81 ± 0.32a
Total n-6 PUFA 19.1 ± 2.7a 25.7 ± 6.7b 20.1 ± 5.1ab 14.9 ± 2.1a 15.9 ± 3.0a
18:3 n-3 0.61 ± 0.17a 0.02 ± 0.01b 0.018 ± 0.003b 0.03 ± 0.02b 0.02 ± 0.01b
20:5 n-3 0.10 ± 0.02 --0.02 ± 0.01 0.02 ± 0.01
22:5 n-3 0.86 ± 0.22a 0.09 ± 0.04b 0.06 ± 0.02b 0.09 ± 0.02b 0.13 ± 0.05b
22:6 n-3 7.7 ± 1.8a 0.58 ± 0.25b 0.66 ± 0.40b 5.4 ± 1.3c 7.0 ± 2.1ac
Total n-3 PUFA 9.3 ± 1.9a 0.69 ± 0.28b 0.74 ± 0.41b 5.6 ± 1.3c 7.1 ± 2.1ac
Total PUFA 28.3 ± 4.5 26.4 ± 6.9 20.8 ± 5.4 20.5 ± 3.2 23.1 ± 5.0
Total HUFA 16.0 ± 4.3 16.2 ± 6.1 12.6 ± 4.4 12.6 ± 2.7 14.7 ± 4.6
% of n-3 HUFA in HUFA 54.2 ± 2.0a 4.1 ± 0.4b 5.7 ± 2.2b 43.8 ± 3.1c 48.6 ± 3.6d
Total FA (mg/g) 15.9 ± 3.5 16.3 ± 9.1 21.2 ± 7.6 21.1 ± 4.6 17.9 ± 6.3
*Values are mean ± SD. Values in a row not sharing a roman superscript are significantly different at P < 0.05 by Tukey's honestly significantly 
difference test after a significant F-value (P < 0.05) by one-way ANOVA. AR-LA, 18:2n-6 artificial reared diet; AR-DPAn-6, 22:5n-6 artificial reared 
diet; AR-DHA+DPAn-6, 22:6n-3 + 22:5n-6 artificial reared diet; AR-DHA, 22:6n-3 artificial reared diet; DMA, dimethyl acetal; PUFA, 
polyunsaturated fatty acids; HUFA, highly unsaturated fatty acids (≥ 20 carbons, ≥ 3 carbon-carbon double bonds)Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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examining the physiological impact of 22:6n-3. Feeding
22:5n-6 in comparison to feeding 22:6n-3 results in fatty
acid composition changes that are largely restricted to
22:5n-6 and 22:6n-3 fatty acids. Feeding with 18:2n-6
feeding appears to increase 20:4n-6. This study also dem-
onstrates that artificial rearing together with the use of
semi-synthetic milk substitute is an effective method to
manipulate skeletal muscle fatty acid compositions and to
induce 22:6n-3 deficiency. The present study also demon-
strates that muscle fibre type discrimination is important
and that 22:6n-3 requirements may differ between fibre
types, possibly in relation to sarcoplasmic reticulum and
mitochondrial oxidation functions. It should be noted
that the high percentage of 22:6n-3 observed in the in red
gastrocnemius of the DAM group is comparable to levels
found in brain in which 22:6n-3 has been demonstrated
to have a critical role in supporting optimal function. The
high level of 22:6n-3 in these muscles is believed to be a
component of phospholipids that support optimal func-
tioning of ion pump activity of sarcoplasmic reticulum
and electron transport in the mitochondria as docosahex-
aenoic acid supports optimal G protein-coupled receptor
signalling in retinal rod outer segments [38]. The defi-
ciency and supplementation model using dietary 22:5n-6
as a comparison group as a presented here would assist in
the elucidation of a specific role of 22:6n-3 in skeletal
muscle physiology.
Methods
Animals and study design
A detailed description of the study design and experimen-
tal diets has been published previously [12]. All experi-
mental procedures were approved by the Animal Care and
Use Committee of the National Institute on Alcohol
Abuse and Alcoholism, NIH. Briefly, pregnant, day 3 of
gestation, Long-Evans rats were purchased (Charles River,
Portage, MI, USA) and fed a 22:6n-3 free, but n-3 fatty acid
adequate diet (3.1% of total fatty acids as α-linolenic acid,
18:3n-3). Animals were maintained in our animal facility
with ad libitum water and at a controlled temperature (23
± 1°C) and a 12-hr light/dark cycle. At postnatal day 2,
male pups were collected from each litter and randomized
to one of five experimental groups. The groups included a
dam-reared group and groups artificially reared on one of
four experimental milks. The composition of the experi-
mental milks was based on an artificial milk with fat con-
tent from hydrogenated coconut oil (Dyets, Bethlehem,
PA, USA), medium chain triglycerides (Mead Johnson
Nutritionals, Evansville, IN, USA) and oleic and linoleic
ethyl esters with purified docosapentaenoic n-6 and/or
docosahexaenoic ethyl esters added (Nu-Chek Prep, Ely-
sian, MN, USA). Thus, the five treatments included a dam-
reared diet (DAM) where the dams received an n-3 fatty
acid adequate (3.1% of total fatty acids as α-linolenic
acid) but 22:6n-3 free diet, and four artificially reared
(AR) groups. The four AR groups received the following
diets: a 15% of total fatty acid 18:2n-6 based diet (AR-LA),
the 18:2n-6 based diet with 1% of total fatty acids 22:5n-
6 (AR-DPAn-6), the LA based diet with 1% of total fatty
acids 22:6n-3 (AR-DHA) and a 18:2n-6 based diet with
1% of total fatty acids 22:6n-3 and 0.4% of total fatty
acids 22:5n-6 diet (AR-DHA+DPAn-6). Details on the
composition of the diets have been presented previously
[12]. A summary of the fatty acid compositions as deter-
mined by gas chromatography are presented in Table 6.
Pups were hand reared until they could feed ad libitum
Table 6: Fatty Acid Composition of Artificial Rat Milk and Pelleted Rat Diets*
Artificial Milk Dam reared AR-LA AR-DPA AR-DHA+DPA AR-DHA
Total saturates n.d. 33.0 33.6 33.0 35.6
Total 
monounsaturates
n.d. 46.9 47.5 46.8 45.5
18:2 n-6 n.d. 18.1 16.0 17.7 16.1
18:3 n-3 n.d. 0.01 0.01 0.01 0.01
22:5 n-6 n.d. - 1.01 0.42 -
22:6 n-3 n.d. - - 0.96 1.16
Pelleted Diet Dam reared AR-LA AR-DPA AR-DHA+DPA AR-DHA
Total saturates 77.2 27.0 27.3 26.5 22.0
Total 
monounsaturates
4.3 46.2 44.5 44.7 47.1
18:2 n-6 15.3 15.4 15.1 15.3 16.3
18:3 n-3 3.1 0.04 0.04 0.04 0.05
22:5 n-6 - - 1.04 0.49 -
22:6 n-3 - - - 0.98 1.10
*Values are weight % of total fatty acids. AR-LA, 18:2n-6 artificial reared diet; AR-DPAn-6, 22:5n-6 artificial reared diet; AR-DHA+DPAn-6, 22:6n-3 
+ 22:5n-6 artificial reared diet; AR-DHA, 22:6n-3 artificial reared diet; n.d., not determined.Lipids in Health and Disease 2007, 6:13 http://www.lipidworld.com/content/6/1/13
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from water bottle nipples after eye opening (postnatal day
14–15) and were eventually weaned to a pelleted diet
with a similar fatty acid composition with the DAM group
transferred to the maternal diet. The male pups underwent
a series of behavioral assessments as described previously
[12] and were killed by decapitation. Soleus and gastroc-
nemius muscles were excised and red and white portions
of the gastrocnemius muscles were separated, frozen on
dry ice and stored at -80°C.
Analysis of muscle fatty acid composition
Total lipids were extracted from muscles by a modified
Folch procedure [39] with docosatrienoic (22:3n-3)
methyl ester (Nu-Chek Prep, Elysian, MN) included as an
internal standard. Fatty acid methyl esters were prepared
with 14% BF3 in methanol according to Morrison and
Smith [40] with a modification to include hexane [41].
Fatty acid methyl esters were analyzed by gas chromatog-
raphy as described previously [41].
Statistical analysis
All statistical analyses were completed with SPSS for Win-
dows statistical software (release 11.5.1; SPPS Inc., Chi-
cago, IL). All data is expressed as mean ± standard
deviation (SD). Comparisons between muscle types of
dam-reared rats were completed by repeated measures
ANOVA with each animal (n = 6) providing a complete set
of the three muscle tissues. The effects of dietary treatment
were compared by the General Linear Model procedure.
Individual means were compared using Tukey's honestly
significant difference test after a significant F-value was
determined. Statistical significance was inferred at P <
0.05. The potential for dietary docosapentaenoic acid to
replace docosahexaenoic acid was examined by t test com-
parisons of 22:5n-6 in the AR-DPAn-6 group with 22:6n-
3 in the AR-DHA group.
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